Developer docs
API playgroundTry for free, no card

Search company profiles

Global Stem Cells

Full company profile

uuid004i1ma

Namestring
Global Stem Cells
Legal namestring
Verita Neuro Pte Ltd
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Global Stem Cells, doing business as Verita Neuro, is a Singapore-incorporated private medical tourism company that facilitates advanced neurological and spinal cord injury treatments for international patients. The company operates a direct-to-consumer model in which prospective patients initiate contact through a free consultation and are then coordinated through dedicated Patient Representatives to treatment delivery at partner hospitals across Thailand, Mexico, Canada, UAE, and Ukraine.

Its treatment portfolio centers on neuromodulation and regenerative medicine, including Epidural Stimulation (electrical stimulation of the spinal cord to encourage restoration of voluntary movement), Brain Stimulation for stroke and traumatic brain injury recovery, LamiSpine (a proprietary surgical procedure combining spinal decompression with stem cell injection), Stem Cell Therapy for neurological and autoimmune conditions, Vagus Nerve Stimulation, and the ReWalk robotic exoskeleton. The company claims to be the first in the world to offer Epidural Stimulation and markets proprietary treatment protocols as competitive differentiators.

Revenue is generated on a per-procedure basis, with pricing determined through individual consultation rather than publicly disclosed. In 2025, the company reported treating 99 patients from 30 countries and delivering 44 Epidural Stimulation surgeries, 71 Stem Cell treatments, and 11 LamiSpine surgeries, alongside 4,983 hours of mapping, 4,075 hours of physical therapy, and 667 hours of occupational therapy. The company maintains a small internal team of five named medical professionals, with treatment delivery executed through trusted international hospital partnerships including Fakeeh University Hospital in Dubai and the Unbroken National Rehabilitation Center in Ukraine.

Short descriptiontext

Verita Neuro (DBA of Global Stem Cells) is a Singapore-based medical tourism company that facilitates advanced neuromodulation and regenerative treatments for international patients with spinal cord injuries and neurological conditions across hospitals in Thailand, Mexico, Canada, UAE, and Ukraine.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSingapore, Singapore, Singapore
HQ citystring
Singapore, Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurological treatment services, spinal cord injury therapy, regenerative medicine, neuromodulation therapy, medical tourism facilitation
Industry2 codes
PRIMARYHLAFAFAH
Neurorehabilitation Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Post-Acute Care & Rehabilitation Facilities
SECONDARYHLADAJAH
Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s)
Healthcare & Life Sciences/Elder Care & Long-Term Care/Rehabilitation & Post-Acute Care Centers (Inpatient/Outpatient)
NAICS code1 code
  • Nursing Care Facilities (Skilled Nursing Facilities)623110
SIC code3 codes
  • Services-Health Services8000
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Neurological Treatment Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Treatment Services
TypeProfessional Services
Description

Revenue is generated through the provision of neurological and spinal cord injury treatments to international patients across its treatment center network. Treatments include epidural stimulation surgery, stem cell therapy, LamiSpine surgery, brain stimulation, vagus nerve stimulation, and rehabilitation programs including the ReWalk exoskeleton. The company operates on a per-procedure/per-treatment basis facilitated through its international hospital partnerships.

veritaneuro.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Verita Neuro is a medical tourism and treatment facilitation company that delivers advanced neurorestorative treatments to international patients with spinal cord injuries, stroke, brain injuries, and other neurological conditions. Its service portfolio includes epidural stimulation, brain stimulation, LamiSpine surgery, stem cell therapy, vagus nerve stimulation, and ReWalk exoskeleton gait training. Treatments are coordinated through dedicated Patient Representatives and delivered via partnerships with international hospitals in Thailand, Mexico, Canada, UAE, and Ukraine.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Voluntary movement restoration in spinal cord injury patients
+6 more records
Product overview1 text field

Verita Neuro is a neurorestorative medical treatment company offering a portfolio of advanced neurological and spinal cord injury treatments. The company pioneered Epidural Stimulation and has developed breakthrough treatments including LamiSpine (combining spinal decompression with stem cell injection), Brain Stimulation, and Stem Cell treatments. Their neuromodulation and regenerative treatments are delivered across treatment centers in Thailand (flagship), Mexico, Canada, UAE, and Ukraine (opening 2026). Treatments include Epidural Stimulation for voluntary movement restoration, Brain Stimulation for stroke/brain injury recovery, LamiSpine for combined surgical and regenerative care, Stem Cell treatments for neurological and autoimmune conditions, Vagus Nerve Stimulation for minimally invasive neuromodulation, and ReWalk Exoskeleton for robotic-assisted mobility. The company reports 99 patients treated from 30 countries in 2025, completing 44 epidural stimulation surgeries, 71 stem cell treatments, and 11 LamiSpine surgeries.

Product and service6 records
1Epidural Stimulation
CategoryNeuromodulation Treatment
Description

Neurorestorative treatment that reconnects pathways between the brain and body through electrical stimulation of the spinal cord, encouraging restoration of voluntary movement in spinal cord injury patients.

2Brain Stimulation
CategoryNeuromodulation Treatment
Description

Neuromodulation treatment targeting stroke and brain injury recovery, aiming to encourage restoration of movement and speech.

3LamiSpine
CategorySpinal Surgery
Description

Proprietary surgical procedure combining spinal decompression with stem cell injection for neurorestorative outcomes in spinal cord treatment.

4Stem Cell Treatment
CategoryRegenerative Treatment
Description

Regenerative treatment utilizing stem cells to help restore function and reduce inflammation in neurological and autoimmune conditions.

5Vagus Nerve Stimulation
CategoryNeuromodulation Treatment
Description

Minimally invasive neuromodulation treatment for stroke and traumatic brain injury recovery.

6ReWalk Exoskeleton
CategoryRehabilitation Equipment
Description

Robotic exoskeleton suitable for paraplegic spinal cord injury patients, enabling walking and stair climbing at home and in everyday life as part of rehabilitation programs.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-07-07
Description

Verita Neuro signed a landmark agreement with the Unbroken National Rehabilitation Center in Lviv, Ukraine to launch a pioneering spinal cord injury treatment center. Opening in 2026, this will be Verita Neuro's first treatment center in Europe, providing neurorestorative care to patients in Ukraine. The partnership was announced on July 7, 2026, and represents a significant strategic expansion into the European market.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based regenerative medicine network offering stem cell and platelet-based treatments for orthopedic and neurological conditions through a clinic franchise model. Comparable in regenerative treatment philosophy, though more US-domestic and clinically conservative.

2Unique Access Medical
TypeDirect peer
Description

Singapore-headquartered medical tourism facilitator offering advanced stem cell and regenerative therapies for neurological and chronic conditions to international patients. Closely mirrors Verita Neuro's Singapore-base, multi-country facilitator model with hospital-based delivery.

TypeDirect peer
Description

Germany-headquartered regenerative medicine provider offering stem cell and immune-modulating therapies for chronic and neurological conditions to an international patient base. Comparable medical-tourism, multi-modality regenerative approach.

TypeDirect peer
Description

Switzerland- and Serbia-based stem cell therapy clinic serving international patients with neurological, autoimmune, and degenerative conditions. Comparable in medical-tourism facilitation model, treatment menu, and out-of-pocket international patient focus.

TypeOthers
Description

Developer of robotic exoskeletons for rehabilitation and spinal cord injury patients. Comparable as a technology supplier in the SCI mobility ecosystem overlapping with Verita Neuro's ReWalk offering.

TypeEmerging player
Description

Clinical-stage company developing epidural stimulation and brain-computer interface technologies for spinal cord injury. Directly comparable on the epidural stimulation technology front but as a research-driven medtech rather than a treatment facilitator.

TypeDirect peer
Description

China-based stem cell processing and treatment provider operating internationally for neurological, orthopedic, and autoimmune conditions. Comparable as a global stem cell therapy provider targeting cross-border patients.

TypeOthers
Description

Developer of the ReWalk exoskeleton, which Verita Neuro actively prescribes and fits to SCI patients. Related as an enabling technology supplier and ecosystem participant rather than a direct treatment competitor.

TypeDirect peer
Description

Global stem cell therapy provider operating hospital-based treatment centers across multiple countries (Mexico, India, UAE, US) targeting neurological, orthopedic, and autoimmune conditions. Directly comparable as a multi-jurisdiction regenerative medicine medical tourism operator.

TypeDirect peer
Description

Mexico-based regenerative medicine clinic offering stem cell therapies for neurological and autoimmune conditions to international patients. Comparable medical-tourism, hospital-based, multi-condition stem cell model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Global Stem Cells

Neurological Treatment Servicesglobalstemcells.com

Verita Neuro (DBA of Global Stem Cells) is a Singapore-based medical tourism company that facilitates advanced neuromodulation and regenerative treatments for international patients with spinal cord injuries and neurological conditions across hospitals in Thailand, Mexico, Canada, UAE, and Ukraine.

What Global Stem Cells does

Global Stem Cells, doing business as Verita Neuro, is a Singapore-incorporated private medical tourism company that facilitates advanced neurological and spinal cord injury treatments for international patients. The company operates a direct-to-consumer model in which prospective patients initiate contact through a free consultation and are then coordinated through dedicated Patient Representatives to treatment delivery at partner hospitals across Thailand, Mexico, Canada, UAE, and Ukraine.

Its treatment portfolio centers on neuromodulation and regenerative medicine, including Epidural Stimulation (electrical stimulation of the spinal cord to encourage restoration of voluntary movement), Brain Stimulation for stroke and traumatic brain injury recovery, LamiSpine (a proprietary surgical procedure combining spinal decompression with stem cell injection), Stem Cell Therapy for neurological and autoimmune conditions, Vagus Nerve Stimulation, and the ReWalk robotic exoskeleton. The company claims to be the first in the world to offer Epidural Stimulation and markets proprietary treatment protocols as competitive differentiators.

Revenue is generated on a per-procedure basis, with pricing determined through individual consultation rather than publicly disclosed. In 2025, the company reported treating 99 patients from 30 countries and delivering 44 Epidural Stimulation surgeries, 71 Stem Cell treatments, and 11 LamiSpine surgeries, alongside 4,983 hours of mapping, 4,075 hours of physical therapy, and 667 hours of occupational therapy. The company maintains a small internal team of five named medical professionals, with treatment delivery executed through trusted international hospital partnerships including Fakeeh University Hospital in Dubai and the Unbroken National Rehabilitation Center in Ukraine.

Global Stem Cells firmographics

Firmographics
Name
Global Stem Cells
Legal name
Verita Neuro Pte Ltd
Website
https://globalstemcells.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Verita Neuro (DBA of Global Stem Cells) is a Singapore-based medical tourism company that facilitates advanced neuromodulation and regenerative treatments for international patients with spinal cord injuries and neurological conditions across hospitals in Thailand, Mexico, Canada, UAE, and Ukraine.
Ownership category
akta.pro rank

Global Stem Cells industry classification

Industry
Product category
Neurological Treatment Services
NAICS
Nursing Care Facilities (Skilled Nursing Facilities) (623110)
SIC
Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAFAFAH
Neurorehabilitation Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Post-Acute Care & Rehabilitation Facilities
SECONDARYHLADAJAH
Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s)
Healthcare & Life Sciences/Elder Care & Long-Term Care/Rehabilitation & Post-Acute Care Centers (Inpatient/Outpatient)

Keywords

  • Neurological treatment services
  • Spinal cord injury therapy
  • Regenerative medicine
  • Neuromodulation therapy
  • Medical tourism facilitation

Where Global Stem Cells is headquartered

Location

Headquarters

HQ city
Singapore, Singapore
HQ country
Singapore
HQ region
Asia

Offices5 records

Markets served

Global Stem Cells business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Medical Treatment Services: Revenue is generated through the provision of neurological and spinal cord injury treatments to international patients across its treatment center network. Treatments include epidural stimulation surgery, stem cell therapy, LamiSpine surgery, brain stimulation, vagus nerve stimulation, and rehabilitation programs including the ReWalk exoskeleton. The company operates on a per-procedure/per-treatment basis facilitated through its international hospital partnerships.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels10 records

Global Stem Cells product offering

Product offering

Core offering

Verita Neuro is a medical tourism and treatment facilitation company that delivers advanced neurorestorative treatments to international patients with spinal cord injuries, stroke, brain injuries, and other neurological conditions. Its service portfolio includes epidural stimulation, brain stimulation, LamiSpine surgery, stem cell therapy, vagus nerve stimulation, and ReWalk exoskeleton gait training. Treatments are coordinated through dedicated Patient Representatives and delivered via partnerships with international hospitals in Thailand, Mexico, Canada, UAE, and Ukraine.

Product overview

Verita Neuro is a neurorestorative medical treatment company offering a portfolio of advanced neurological and spinal cord injury treatments. The company pioneered Epidural Stimulation and has developed breakthrough treatments including LamiSpine (combining spinal decompression with stem cell injection), Brain Stimulation, and Stem Cell treatments. Their neuromodulation and regenerative treatments are delivered across treatment centers in Thailand (flagship), Mexico, Canada, UAE, and Ukraine (opening 2026). Treatments include Epidural Stimulation for voluntary movement restoration, Brain Stimulation for stroke/brain injury recovery, LamiSpine for combined surgical and regenerative care, Stem Cell treatments for neurological and autoimmune conditions, Vagus Nerve Stimulation for minimally invasive neuromodulation, and ReWalk Exoskeleton for robotic-assisted mobility. The company reports 99 patients treated from 30 countries in 2025, completing 44 epidural stimulation surgeries, 71 stem cell treatments, and 11 LamiSpine surgeries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Epidural Stimulation Neurorestorative treatment that reconnects pathways between the brain and body through electrical stimulation of the spinal cord, encouraging restoration of voluntary movement in spinal cord injury patients.
  • Brain Stimulation Neuromodulation treatment targeting stroke and brain injury recovery, aiming to encourage restoration of movement and speech.
  • LamiSpine Proprietary surgical procedure combining spinal decompression with stem cell injection for neurorestorative outcomes in spinal cord treatment.
  • Stem Cell Treatment Regenerative treatment utilizing stem cells to help restore function and reduce inflammation in neurological and autoimmune conditions.
  • Vagus Nerve Stimulation Minimally invasive neuromodulation treatment for stroke and traumatic brain injury recovery.
  • ReWalk Exoskeleton Robotic exoskeleton suitable for paraplegic spinal cord injury patients, enabling walking and stair climbing at home and in everyday life as part of rehabilitation programs.

Quantifiable outcome

  • Voluntary movement restoration in spinal cord injury patients
  • +6 more outcomes

Companies that use Global Stem Cells

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Global Stem Cells technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Global Stem Cells partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Unbroken National Rehabilitation Center (Ukraine)flagshipStrategic or Co-development Partner · 7 July 2026Verita Neuro signed a landmark agreement with the Unbroken National Rehabilitation Center in Lviv, Ukraine to launch a pioneering spinal cord injury treatment center. Opening in 2026, this will be Verita Neuro's first treatment center in Europe, providing neurorestorative care to patients in Ukraine. The partnership was announced on July 7, 2026, and represents a significant strategic expansion into the European market.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Global Stem Cells competitors and assessment

Company assessment

Direct peers

  • Regenexx: US-based regenerative medicine network offering stem cell and platelet-based treatments for orthopedic and neurological conditions through a clinic franchise model. Comparable in regenerative treatment philosophy, though more US-domestic and clinically conservative.
  • Unique Access Medical: Singapore-headquartered medical tourism facilitator offering advanced stem cell and regenerative therapies for neurological and chronic conditions to international patients. Closely mirrors Verita Neuro's Singapore-base, multi-country facilitator model with hospital-based delivery.
  • Infusio: Germany-headquartered regenerative medicine provider offering stem cell and immune-modulating therapies for chronic and neurological conditions to an international patient base. Comparable medical-tourism, multi-modality regenerative approach.
  • Swiss Medica: Switzerland- and Serbia-based stem cell therapy clinic serving international patients with neurological, autoimmune, and degenerative conditions. Comparable in medical-tourism facilitation model, treatment menu, and out-of-pocket international patient focus.
  • Beike Biotechnology: China-based stem cell processing and treatment provider operating internationally for neurological, orthopedic, and autoimmune conditions. Comparable as a global stem cell therapy provider targeting cross-border patients.
  • GIOSTAR (Global Institute of Stem Cell Therapy & Research): Global stem cell therapy provider operating hospital-based treatment centers across multiple countries (Mexico, India, UAE, US) targeting neurological, orthopedic, and autoimmune conditions. Directly comparable as a multi-jurisdiction regenerative medicine medical tourism operator.
  • Stemaid Institute: Mexico-based regenerative medicine clinic offering stem cell therapies for neurological and autoimmune conditions to international patients. Comparable medical-tourism, hospital-based, multi-condition stem cell model.

Others

  • Ekso Bionics: Developer of robotic exoskeletons for rehabilitation and spinal cord injury patients. Comparable as a technology supplier in the SCI mobility ecosystem overlapping with Verita Neuro's ReWalk offering.
  • ReWalk Robotics: Developer of the ReWalk exoskeleton, which Verita Neuro actively prescribes and fits to SCI patients. Related as an enabling technology supplier and ecosystem participant rather than a direct treatment competitor.

Emerging players

  • ONWARD Medical: Clinical-stage company developing epidural stimulation and brain-computer interface technologies for spinal cord injury. Directly comparable on the epidural stimulation technology front but as a research-driven medtech rather than a treatment facilitator.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Global Stem Cells social profiles

Digital presence

Global Stem Cells financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Global Stem Cells leadership team

Management profile

Number of profiles

Profiles5 records

Global Stem Cells funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Global Stem Cells M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Stem Cells

What does Global Stem Cells do?

Verita Neuro is a medical tourism and treatment facilitation company that delivers advanced neurorestorative treatments to international patients with spinal cord injuries, stroke, brain injuries, and other neurological conditions. Its service portfolio includes epidural stimulation, brain stimulation, LamiSpine surgery, stem cell therapy, vagus nerve stimulation, and ReWalk exoskeleton gait training. Treatments are coordinated through dedicated Patient Representatives and delivered via partnerships with international hospitals in Thailand, Mexico, Canada, UAE, and Ukraine.

Is Global Stem Cells a public or private company?

Global Stem Cells is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Global Stem Cells founded?

Global Stem Cells was founded in 2015. It employs 1 to 10 people.

Where is Global Stem Cells based?

Global Stem Cells is headquartered in Singapore, Singapore, Singapore, in the Asia region.

How does Global Stem Cells make money?

One revenue line is on record: medical Treatment Services.

Who are Global Stem Cells's main competitors?

Direct peers on record are Regenexx, Unique Access Medical, Infusio, Swiss Medica, Beike Biotechnology, GIOSTAR (Global Institute of Stem Cell Therapy & Research) and Stemaid Institute. Others are Ekso Bionics and ReWalk Robotics. ONWARD Medical is listed as an emerging player.

Does Global Stem Cells have an API?

No public API is recorded for Global Stem Cells.

What industry is Global Stem Cells in?

Global Stem Cells's product category is Neurological Treatment Services. Its primary akta.pro industry code is HLAFAFAH, Neurorehabilitation Centers, with a secondary code of HLADAJAH, Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s). Its NAICS code is 623110 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales